Experiences with
Tukysa

3 public posts

The FDA has approved a treatment for #metastatic #her2positive #colorectalcancer.

Learn more here: https://investor.seagen.com/press-releases/news-details/2023/Seagen-Announces-FDA-Accelerated-Approval-of-TUKYSA-tucatinib-in-Combination-with-Trastuzumab-for-People-with-Previously-Treated-RAS-Wild-Type-HER2-Positive-Metastatic-Colorectal-Cancer/default.aspx

Learn more here: https://investor.seagen.com/press-releases/news-details/2023/Seagen-Announces-FDA-Accelerated-Approval-of-TUKYSA-tucatinib-in-Combination-with-Trastuzumab-for-People-with-Previously-Treated-RAS-Wild-Type-HER2-Positive-Metastatic-Colorectal-Cancer/default.aspx

Administratorin Colon Cancer Connected

2 years ago

Revisiting the Bob Beck protocol for cancer and other illnesses

It’s not a traditional therapy, (although most of what I post here isn’t~) Having been diagnosed stage 4 since 2020, I’m currently on my 4th line of treatment now (Xeloda, Herceptin, Tukysa currently).

It’s not a traditional therapy, (although most of what I post here isn’t~) Having been diagnosed stage 4 since 2020, I’m currently on my 4th line of treatment now (Xeloda, Herceptin, Tukysa currently).

in SHARE Metastatic Breast Cancer

2 years ago

Good News for HER2 Positive MBC Patients!

If your cancer is HER2 positive and you’ve already had one or more HER2-directed therapies for metastatic disease, then you’re eligible to receive the newly-approved combination of the oral drug Tukysa (Tucatinib) with Xeloda (capecitabine) and Herceptin (or an approved biosimilar).

If your cancer is HER2 positive and you’ve already had one or more HER2-directed therapies for metastatic disease, then you’re eligible to receive the newly-approved combination of the oral drug Tukysa (Tucatinib) with Xeloda (capecitabine) and Herceptin (or an approved biosimilar).

in SHARE Metastatic Breast Cancer

5 years ago

Want to take advantage of all our features? Just log in!

or